Quote from Retief:
Better hope you die of something besides cancer because UBS is about to put DNDN out of operation. Who gives a crap really? Isn't it more important for Steve Cohen to be able to buy more art work, than for more effective cancer treatments to be made available?
Selective quoting only makes your argument look weaker.
A) TASR, TZOO and OSTK were no penny stocks when they were manipulating float. SEC did nothing cause these were hot CNBC stocks and those same naked shorters were probably playing the long side. Hmmm.
B) I clearly stated it is an issue of capitalization and no naked shorters will go up against big money institutions. So they aim for stocks that are not worth big money's attention.
C) I do not take drugs or vaccines, I hate pharmaceutical pill pushers, so IMO, screw those companies anyway. But in a bigger sense, it is way too dangerous to short down a biotech, unless it was known that it was full of sh*t. Ever see the reactions of FDA announcements when big money suddenly jumps in?
Re-read my whole post, I'm more in the middle, I think NSS has been taken to absurd levels but I have no sympathy for these weak whiny excuses being made by types like the OSTK CEO. Please, their financials show that he is lucky it's not a sub $5 dollar stock, let alone sub $10. Quite an EPS that stock has.